Differentiated thyroid cancer (DTC)
Clinical trials for Differentiated thyroid cancer (DTC) explained in plain language.
Never miss a new study
Get alerted when new Differentiated thyroid cancer (DTC) trials appear
Sign up with your email to follow new studies for Differentiated thyroid cancer (DTC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer patients to continue promising treatments in major extension trial
Disease control By invitation onlyThis long-term extension study offers continued access to several cancer drugs—including cabozantinib, atezolizumab, and nivolumab—for up to 5,000 patients who benefited from them in earlier Exelixis-sponsored trials. The study focuses on monitoring safety and ongoing clinical be…
Matched conditions: DIFFERENTIATED THYROID CANCER (DTC)
Phase 3 • Sponsor: Exelixis • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New pill combo shows promise for tough thyroid cancer
Disease control OngoingThis phase 3 study tests whether two targeted cancer pills, dabrafenib and trametinib, can help people with advanced thyroid cancer that has a specific gene change (BRAF V600E) and no longer responds to radioactive iodine. About 153 adults who have already tried one or two other …
Matched conditions: DIFFERENTIATED THYROID CANCER (DTC)
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC